Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.

b'Host: Atul Malhotra, MD
\\n\\n Host: Neomi Shah, MD, MPH, MSc
\\n\\n\\n \\n

This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

'